MYHEP ALL

Myhep All tablet includes the active ingredients Sofosbuvir and Velpatasvir.

Myhep All is utilized for the treatment of chronic hepatitis C. Hepatitis C is a liver infection that results from the hepatitis C virus (HCV). The length of treatment is typically shorter than that of older treatment protocols. This duration may vary based on factors such as the HCV genotype, prior treatment history, and the existence of liver cirrhosis.

Effective treatment with Myhep All tablet can greatly diminish liver inflammation and fibrosis associated with HCV infection. By achieving viral clearance, the likelihood of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a form of liver cancer) can be significantly lowered.

If you are allergic or hypersensitive to Myhep All tablet or any of its components, you should refrain from using it. The safety and effectiveness of the sofosbuvir and velpatasvir combination therapy have not been confirmed for children under 18 years of age. Its application in the pediatric demographic is currently restricted. It is advisable to consider alternative treatment methods or modify the dosage in such situations. Additionally, you can purchase Myhep All online from any location.